Microbiota & Microbiotal Medicine: Where We are Now & What’s Next?
Dr. Marvin Edeas, Founder & Chairman of ISM, Institut Cochin, INSERM, Université de Paris, France, will introduce the 9th Targeting Microbiota meeting and he will talk about "Microbiota & Microbiotal Medicine: Where We are Now & What’s Next?".
The aim of Dr. Marvin Edeas is to introduce a new way of thinking about the medicine of tomorrow. He will initiate the reflection and discussion about strategies which will allow us to accelerate Microbiotal medicine.
Dr. Marvin Edeas will try to discuss:
- Why we failed to treat many diseases?
- Do we need to dedicate a specific treatment to one specific organ or specific pathology?
Dr. Marvin Edeas believes that the medicine of tomorrow will connect all organs together and with our microbiota and microbiome. All therapeutic strategies will come through the way we will take into consideration the quality of Microbiota and metabolites, signaling pathways, epigenetic and more.
Dr. Edeas thinks that we are still at the beginning in our exploration and we probably need to desiccate more the mechanism behind microbiota efficacy such as: extracellular vesicles and exosomes and their impact on microbiota communication and microbiota-host relationship, along with their potential implication in disease. Further explore the role of microbiota and its metabolites on iron metabolism should be highlighted.
He will discuss the 4 main axes that should be exploreed in the furture:
- Olfactory receptors;
- Brain and behaviour;
- Ageing & longevity;
- Artificial intelligence and algorithms.
Reference: Microbiota medicine: towards clinical revolution - BMC Journal of Translational Medicine
Join Targeting Microbiota 2022 to learn more about the future of microbiotal medicine.
Targeting Microbiota 2022 Congress
October 19-21, 2022 - Paris, France
www.microbiota-site.com
